Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2055-2066

  Ziswiler, Ruth ^a   Steinmann Niggli, Karin ^a   Kappeler, Andreas ^b   Daniel, Catherine ^a   Marti, Hans Peter ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CREATININE; FIBRONECTIN; GUANOSINE; MYCOPHENOLIC ACID; THYMOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; EXTRACELLULAR MATRIX; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031759148     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Räisänen-Sokolowski A, Vuoristo P, Myllärniemi M, Yilmaz S, Kallio E, Häyry P: Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transplant Immunol 3: 342-351, 1995
2. Allison AC, Eugui EM: Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10: 77-84, 1996
3. Pirsch JD, Sollinger HW: Mycophenolate mofetil: Clinical and experimental experience. Ther Drug Monit 18: 357-361, 1996
4. Johnson RJ, Iida H, Alpers CE, Majeski MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87: 847-858, 1991
5. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies: A sequential histological and ultrastructural study in the rat. Lab Invest 55: 680-687, 1986
6. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991
7. Lovett DH, Johnson RJ, Marti HP, Martin J, Davies M, Couser WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141: 85-98, 1992
8. Martin J, Davies M, Thomas G, Lovett DH: Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 36: 790-801, 1989
9. Davies M, Thomas GJ, Martin J, Lovett DH: The purification and characterization of a glomerular basement membrane-degrading neutral proteinase from rat mesangial cells. Biochem J 251: 419-425, 1988
10. Martin J, Lovett DH, Gemsa D, Sterzel RB, Davies M: Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: Role of interleukin 1. J Immunol 137: 525-529, 1986
11. Marti HP, McNeil L, Davies M, Martin J, Lovett DH: Homology cloning of rat 72 kDa type IV collagenase: Cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem J 291: 441-446, 1993
12. Marti HP, McNeil L, Thomas G, Davies M, Lovett DH: Molecular characterization of a low molecular weight matrix metallo-proteinase secreted by glomerular mesangial cells as Pump-1. Biochem J 285: 899-905, 1992
13. Southgate K, Newby AC: Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis 82: 113-123, 1990
14. Steinmann-Niggli K, Lukes M, Marti HP: Rat mesangial cells and matrix metalloproteinase inhibitor: Inhibition of 72-kDa type IV collagenase (MMP-2) and of cell proliferation. J Am Soc Nephrol 8: 395-405, 1997
15. Allison AC, Almquist SJ, Muller CD, Eugui EM: In vitro immunosuppressive effects of mycophenolic acid and ester prodrug, RS 61443. Transplant Proc 23[Suppl 2]: 10-14, 1991
16. Senda M, DeLustro B, Eugui E, Natsumeda Y: Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 60: 1143-1148, 1995
17. Broestl JA, Emancipator SN: Rat mesangial cell lysis in vitro is induced by cationic polypeptides. Am J Pathol 142: 529-539, 1993
18. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ: Tumor necrosis factor α and interleukin 1β enhance the cortisone/ cortisol shuttle. J Exp Med 186: 189-198, 1997
19. Lavaud S, Michel O, Sassy-Prigent C, Heudes D, Bazin R, Bariéty J, Chevalier J: Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 7: 2604-2615, 1996
20. Eitner F, Westerhuis R, Burg M, Weinhold B, Gröne H-J, Ostendorf T, Rüthner U, Koch K-M, Rees A, Floege J: Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 51: 69-78, 1997
21. Mason DW, Williams AF: The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J 187: 1-20, 1980
22. Falkenberg FW, Hengelage T, Krane M, Bartels I, Albrecht A, Holtmeier N, Wüthrich M: A simple and inexpensive high-density dialysis tubing cell culture system for the in vitro production of monoclonal antibodies in high concentration. J Immunol Methods 165: 193-206, 1993
23. Lindmark R, Thorén-Tolling K, Sjöquist J: Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera. J Immunol Methods 62: 1-13, 1983
24. Gibaldi M, Perrier D: Appendix D. In: Pharmacokinetics, New York, Marcel Dekker, 1982, pp 445-449
25. Steinmann-Niggli K, Ziswiler R, Küng M, Marti HP: Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis. J Am Soc Nephrol 9: 397-407, 1998
26. Laulajainen T, Julkunen I, Haltia A, Knuutila S, Miettinen A, Holthöfer H: Establishment and characterization of a rat glomerular endothelial cell line. Lab Invest 69: 183-192, 1993
27. Roy-Chaudhury P, Wu B, McDonald S, Haites NE, Simpson JG, Power DA: Phenotypic analysis of the glomerular and periglomerular mononuclear cell infiltrates in the Thy 1.1 model of glomerulonephritis. Lab Invest 72: 524-531, 1995
28. Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy A, Johnson RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor: Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 90: 2362-2369, 1992
29. Studer H, Gerber H, Zbaeren J, Peter HJ: Histomorphological and immuno-histochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. J Clin Endocrinol Metab 75: 1151-1158, 1992
30. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
31. Turck J, Pollock AS, Lee LK, Marti HP, Lovett DH: Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271: 15074-15083, 1996
32. Lewis JH, van Thiel DH, Hasiba U, Spero JA, Gavaler J: Comparative hematology and coagulation: Studies on rodentia (rats). Comp Biochem Physiol A 82: 211-215, 1985
33. Floege J, Eng E, Young B, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vivo and in vitro. Kidney Int Suppl 43: S47-S54, 1993
34. Yokozawa T, Oura H, Ienaga K, Nakamura K: Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure. Nephron 64: 424-428, 1993
35. Rodriguez-Barbero A, Bosque E, Gonzalez-Buitrago JM, Garcia-Bastos JL, Lopez-Novoa JM: Gentamicin nephrotoxicity in rats is not modified by verapamil. Arch Int Physiol Biochim Biophys 101: 395-397, 1993
36. Lee G, Glassock RJ: Immunoglobulin A nephropathy. In: Treatmem of Primary Glomerulonephritis. Oxford Clinical Nephrology Series, edited by Ponticelli C, Glassock RJ, New York, Oxford University Press, 1997, pp 186-217
37. Hogg RJ, Waldo B: Advances in treatment: Immunoglobulin A nephropathy. Semin Nephrol 16: 511-516, 1996
38. Black RM, Rose BD: Clinical Problems in Nephrology, 1st Ed., edited by Black RM, Boston, Little, Brown and Co., 1996, pp 317-323
39. Fulton B, Markham A: Myophenolate mofetil. Drugs 51: 278-298, 1996
40. Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL: Effects of RS-61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59: 460-466, 1995
41. Räisänen-Sokolowski A, Aho P, Myllärniemi M, Kallio E, Häyry P: Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443). Transplant Proc 27: 435, 1995
42. Bagchus WM, Jeunink MF, Elema JD: The mesangium in antiThy-1 nephritis: Influx of macrophages, mesangial cell hypercellularity and macromolecular accumulation. Am J Pathol 137: 215-223, 1990
43. Nowack R, Birck R, van der Waude J: Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 349: 774, 1997
44. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G: Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int 51: 1583-1589, 1997
45. Chanaud NP III, Vistica BP, Eugui E, Nussenblatt RB, Allison AC, Gery I: Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism. Exp Eye Res 61: 429-434, 1995
46. Steele DM, Hullett DA, Bechstein WO, Kowalski J, Smith LS, Kennedy E, Allison AC, Sollinger HW: Effects of immunosuppressive therapy on the rat aortic allograft model. Transplant Proc 25: 754-755, 1993
47. Morris RE, Wang J, Blum JR, Flavin T, Murphy MP, Almquist SJ, Chu N, Tam YL, Kaloostian M, Allison AC, Eugui EM: Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhumane primate recipients of heart allografts. Transplant Proc 23: 19-25, 1991
48. Goldblum R: Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 11: S117-S119, 1993
49. Schiff MH, Goldblum R, Rees MMC: 2-Morpholino-ethyl mycophenolic acid (ME-MPA) in the treatment of refractory rheumatoid arthritis (RA) [Abstract]. Arthritis Rheum 33: 155, 1990
50. Epinette WW, Parker CM, Jones EL, Greist MC: Mycophenolic acid for psoriasis. J Am Acad Dermatol 17: 962-971, 1987
51. Penny MJ, Boyd RA, Spinelli A, Hall BM: Mycophenolate mofetil prevents induction, but does not reverse proteinuria in active Heymann nephritis [Abstract]. J Am Soc Nephrol 6: 848, 1995